• Corpus ID: 19572656

Uterine sarcoma: a clinicopathological study of 93 cases.

  title={Uterine sarcoma: a clinicopathological study of 93 cases.},
  author={Eduardo Gonz{\'a}lez-Bosquet and Jos{\'e} M. Mart{\'i}nez-Palones and Jesus Gonzalez-Bosquet and A Garc{\'i}a Jim{\'e}nez and Jordi Xercavins},
  journal={European journal of gynaecological oncology},
  volume={18 3},
OBJECTIVE To evaluate the clinical outcome of patients suffering from primary uterine sarcoma diagnosed and treated in our Hospital. SETTING Department of Gynecologic Surgery/Gynecologic Oncology, Hospital Universitario Materno-Infantil Vall d'Hebron de Barcelona, Barcelona, Spain. SUBJECTS AND METHODS A retrospective review from 1967 to 1995 of clinical and pathological characteristics of 93 patients with primary uterine sarcoma was done. Patients were staged using the 1988 FIGO… 
Clinical Characteristics and Treatment Modalities in Uterine Sarcoma
Uterine sarcoma is an aggressive tumor with a poor prognosis and the major treatment is surgery and the role of adjuvant chemotherapy or radiotherapy still remains undetermined.
Prognostic factors and treatment outcomes of patients with uterine sarcoma: analysis of 127 patients at a single institution, 1989–2007
It is suggested that complete cytoreduction is important and adjuvant chemotherapy can help achieve favorable prognoses in patients with advanced stage disease, however, postmenopausal status, advanced FIGO stage, deep myometrial invasion, and positive LVSI were associated with poor prognosis.
Management of Uterine Sarcomas
The management of uterine sarcomas is multidisciplinary, based mainly on surgery remains the only means of cure, and decreased risk of local recurrence, with no impact on survival achieved at best 30% at 5 years.
Diagnosis and surgical therapy of uterine sarkoma
Adequate diagnosis and treatment of uterine sarcoma is possible with regular yearly or more frequent follow-up, especially in postmenopausal women with known risk factors present, according to a retrospective study of patients with clinical and pathological characteristics.
Prognostic Factors and Treatment Modalities in Uterine Sarcoma
The aim of this study was to identify the impact of various prognostic factors in the management of uterine sarcoma and found that grade I tumors, ESS, nonmetastatic stage, and negative peritoneal cytology were associated with better overall survival.
Adjuvant pelvic radiotherapy for uterine carcinosarcoma in a high risk population.
  • T. Le
  • Medicine
    European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology
  • 2001
Uterine carcinosarcoma is a rare and aggressive form of uterine malignancy even in early stages and adjuvant pelvic radiotherapy seems to improve the progression-free survival and overall survival in patients with poor histologic prognostic factors.
The role of lymphadenectomy in uterine leiomyosarcoma: review of the literature and recommendations for the standard surgical procedure
Whether lymphadenectomy affects the 5-year DSS, as well as other relevant clinical outcomes, in women with uterine leiomyosarcomas is investigated and a critical account of the management strategies of these tumors is presented.
Response of recurrent uterine high-grade malignant mixed müllerian tumor to letrozole.
The case of a 69-year-old woman with recurrent metastatic high-grade uterine MMMT that responded to letrozole, an aromatase inhibitor, that demonstrated marked tumor shrinkage is reported.
Leiomyosarcomna Presenting as Abdominal Pain in a 50 Years Old Woman: A Case Report
Any post menopausal woman having persistent abdominal pain and a clinical and USG diagnosis of fibroid a differential of leiomyosarcoma should be borne in mind of the physicians.